Evaluation of the clinical usefulness of isolation of fetal DNA from the maternal circulation

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 43, Issue 1, 2003, Pages 10-15

  Siva, Sashi C ^a   Johnson, Sylvia I ^b   McCracken, Sharon A ^b   Morris, Jonathan M ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Fetal DNA; Maternal blood; Prenatal detection; RhD polymerase chain reaction (PCR); Sex determing region Y PCR

Indexed keywords

BETA GLOBIN; DNA; PRIMER DNA; RHESUS ANTIBODY; RHESUS D ANTIBODY;

ADULT; AMNIOCENTESIS; ARTICLE; BLOOD ANALYSIS; BLOOD GROUP RH; BLOOD SAMPLING; CHORION VILLUS SAMPLING; CIRCULATION; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DELIVERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; DNA EXTRACTION; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; FETUS; FETUS CELL; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; KARYOTYPE; MALE; MATERNAL BLOOD; MEDICAL ASSESSMENT; MICROBIAL CONTAMINATION; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; RHESUS INCOMPATIBILITY; SECOND TRIMESTER PREGNANCY; SEX DETERMINATION; SRY GENE; UMBILICAL CORD BLOOD;

CHROMOSOMES, HUMAN, Y; DNA; FEMALE; FETUS; HUMANS; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; RH-HR BLOOD-GROUP SYSTEM; SEX DETERMINATION (ANALYSIS); SPECIMEN HANDLING;

EID: 0038634548     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0004-8666.2003.00011.x     Document Type: Article

References (23)

1. Bianchi DW. Fetal cells in the maternal circulation: Feasibility for prenatal diagnosis. Br J Haematol. 1999; 105: 574-583.
2. Lo YM, Zhang J, Leung TN, Lau T, Chang AMZ, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999; 64: 218-224.
3. Lo YM, Tein MS, Lau TK et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998; 62: 768-775.
4. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997; 350: 485-487.
5. Bianchi DW. Fetal DNA in maternal plasma: The plot thickens and the placental barrier thins. Am J Hum Genet. 1998; 62: 763-764.
6. Falcinelli C, Battafarano S, Neri C et al. First-trimester fetal sex prediction by deoxyribonucleic acid analysis of maternal peripheral blood. Am J Obstet Gynecol. 1999; 181: 675-680.
7. Houfflin-Debarge V, O'Donnell H, Overton T, Bennett PR, Fisk NM. High sensitivity of fetal DNA in plasma compared to serum and nucleated cells using unnested PCR in maternal blood. Fetal Diagn Ther. 2000; 15: 102-107.
8. Faas BH, Beuling EA, Christiaens GC, von dem Borne AE, van der Schoot CE. Detection of fetal RHD-specific sequences in maternal plasma. Lancet. 1998; 352t: 1196.
9. Lo YM, Hjelm NM, Fidler C et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med. 1998; 339: 1734-1738.
10. QIAamp DNA. Blood Minikit Handbook. Melbourne: Qiagen.
11. Nelson M, Eagle C, Langshaw M, Popp H, Kronenberg H. Genotyping fetal DNA by non-invasive means: extraction from maternal plasma. Vox Sang. 2001; 80: 112-116.
12. Chan FY, Cowley NM, Wolter L, Stone M, Carmody F, Saul A, Hyland CA. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation. Prenat Diagn. 2001; 21: 321-326.
13. Tang N, Leung T, Zhang J, Lau TK, Lo YM. Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clin Chem. 1999; 45: 2033-2035.
14. Chen CP, Chern SR, Wang W. Fetal DNA in maternal plasma: the prenatal detection of a paternally inherited fetal aneuploidy. Prenat Diagn. 2000; 20: 355-357.
15. Amicucci P, Gennarelli M, Novelli G, Dallapicola B. Prenatal diagnosis of myotonic dystrophy obtained from maternal plasma. Clin Chem. 2000; 46: 301-302.
16. Rijnders RJ, van der Schoot CE, Bossers B, de Vroede MA, Christiaens GC. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol. 2001; 98: 374-378.
17. Pertl B, Sekizawa A, Samura O, Orescovic I, Rahaim PT, Bianchi DW. Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats. Hum Genet. 2000; 106: 45-49.
18. Lo YM, Lau TK, Zhang J et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem. 1999; 45: 1747-1751.
19. Poon LL, Leung TN, Lau TK, Lo YM. Prenatal detection of fetal Down's syndrome from maternal plasma. Lancet. 2000; 356: 1819-1829.
20. Lo, YM, Leung TN, Tein MS et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem. 1999; 45: 184-188.
21. Zhong XY, Holgreve W, Hahn S. Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann NY Acad Sci. 2001; 945: 138-140.
22. Lo YM. Fetal DNA in maternal plasma. Ann NY Acad Sci. 2000; 906: 141-147.
23. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. Maternal plasma fetal DNA as a marker for preterm labour. Lancet. 1998; 352: 1904-1905.